The Project Management Institute Announces Winners of 2020 PMI® Awards
16.11.2020 17:45:00 EET | Business Wire | Press release
On Tuesday, 20 October, Project Management Institute (PMI) announced the winners of the 2020 PMI® Professional Awards during the Virtual Experience Series event, A New World View: Our Global Impact.
Since 1974, the prestigious PMI Professional Awards have honored organizations and individuals whose passion, talent, and expertise have made the greatest contributions to the project management profession or to PMI.
This year’s PMI Research and Academic Award winners have also been selected. These awards recognize those who have made sustained or significant contributions through teaching, research, or literature.
For more information on the award programs: https://www.pmi.org/about/awards.
PMI® Professional Awards:
PMI Project of the Year – This award recognizes the large and complex project that best delivers superior performance of project management practices, superior organizational results, and positive impacts on society with a project budget of more than US$100 million.
- Winner: The Trans Anatolian Natural Gas Pipeline (TANAP) Project, TANAP Natural Gas Transmission Company (Ankara, Turkey)
- Finalist: Revitalisation de la Tour de Montréal – Montréal Tower Revitalization Project, Parc Olympique (Montréal, Québec, Canada)
- Finalist: Fort McMurray West 500 kV Transmission Project, ATCO (Edmonton, Alberta, Canada)
PMO OF THE YEAR® Award– This award honors a Project Management Office (PMO) that has added value to its organization through its support of successful strategic initiatives and demonstrated superior organizational project management capabilities. It also recognizes a PMO that has established a vision for value delivery and has had a positive and clear impact on business results.
- Winner: DC Water – IT Project Management Office : IT Project Management Office – Making I.T. Happen, (Washington, D.C., U.S.)
- Finalist: Emaar Properties PJSC – Group Operations: Emaar Properties - Group Operations: Strategic Project Management Office(Dubai, United Arab Emirates)
- Finalist: Kern Health Systems: Kern Health Systems Enterprise Project Management Office(Bakersfield, California, U.S.)
PMI Project Excellence Award – This award recognizes complex projects that best deliver superior performance of project management practices, superior organizational results, and positive impacts on society with a project budget of less than US$100 million.
- Asia Pacific Region: PROJECT RURAL MPOWERMENT, Mobitel (Pvt) Ltd (Colombo, Sri Lanka)
- Europe, Middle East, Africa Region: Shaybah Airport Runway Upgrade Project, Saudi Aramco – Oil Facilities Projects Department (Dhahran, Saudi Arabia)
- North America Region: Data-Center Co-Location Project, Adventist Health/ Highmark Solutions (Roseville, California, USA)
PMI Fellow Award – This is the highest and most prestigious individual award presented by Project Management Institute for service to the organization and profession.
- Marge Combe, PMI Fellow
- Dr. Prasad S. Kodukula, PMP, PgMP, PMI Fellow
PMI Eric Jenett Project Management Excellence Award – This award recognizes and honors an individual who has made an outstanding contribution(s) to the project management profession or its practice through leadership, technical project management, and strategic and business management acumen.
- Vanita Ahuja, PhD, PgMP, MRICS
- Dr. Krishna Kumar T I PhD, CDAI
- Kenneth Bainey MBA, PMP
PMI Young Professional Award – This award recognizes and honors young professionals who have made a significant impact in advancing project management within an organization, advancing the knowledge and understanding of the practice of project management, and demonstrating an understanding of PMI standards, practices and ethics.
- Nguyen Si Trieu Chau, LIMC, PfMP, PgMP, PMP, PMI-ACP, PMI-RMP, PMI-SP, IPMO-E, PMO-CP
- Lt. Dimitrios Zaires Exec. MSc, MBA, CMILT, PMI-RMP
- Roman Reznikov
- Dr. Ritu Ahuja, PMI-ACP, MRICS
PMI® Research and Academic Award Winners:
PMI Research Achievement Award – This award recognizes and honors an individual or group of individuals whose work has significantly advanced the concepts, knowledge, and practices of project management through a published body of academic research.
- Professor Monique Aubry, PhD, MPM
PMI Linn Stuckenbruck Teaching Excellence Award – This award recognizes and honors an individual faculty member for excellence in teaching project management, and for their strong commitment to improving and enhancing project management curricula in higher education.
- Callum Robert Kidd (University of Manchester)
PMI Project Management Journal® Paper of the Year Award – This award recognizes the best paper published in the Project Management Journal in the previous year.
- “How Digital Information Transforms Project Delivery Models” by Professor Jennifer Whyte
PMI David I. Cleland Project Management Literature Award – This award recognizes the author(s) of a published book that significantly advances project management knowledge, concepts, and practice.
- “Project Management: A Benefit Realisation Approach” by Professor Ofer Zwikael and John R Smyrk
Find the list of PMI award winners: https://www.pmi.org/about/awards/winners
About Project Management Institute (PMI)
Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Through global advocacy, collaboration, education and research, we work to prepare more than three million professionals around the world for The Project Economy: the coming economy in which work, and individuals, are organized around projects, products, programs and value streams. Now 50 years in the making, we work in nearly every country around the world to advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com® interactive website creates online global communities that deliver more resources, better tools, larger networks and broader perspectives. Visit us at www.PMI.org, www.projectmanagement.com, www.facebook.com/PMInstitute and on Twitter @PMInstitute
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201116005763/en/
Contact information
Media:
Drew Pradeep
Tel: 610-416-6023
Drew.Pradeep@pmi.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
